Description
Product details
BUDESHINE F 400 CAP—This is a combination inhalation therapy used in the management of asthma and chronic obstructive pulmonary disease (COPD). Mechanism of Action: Formoterol Fumarate: A long-acting β₂-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation. Budesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production. Together, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation. Indications: Asthma (for patients not controlled adequately with inhaled corticosteroids alone). Chronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction. Prevention of asthma attacks and reduction of COPD exacerbations. Key Benefits: Provides fast and sustained relief from breathing difficulty. Controls both inflammation and bronchospasm. Reduces the frequency and severity of asthma/COPD flare-ups. Improves overall lung function and quality of life. Dosage and Administration: Administered via inhalation as directed by a physician. The dose depends on the severity of disease and patient response. Regular use is required for effective control—not for acute asthma attacks. (Exact dosing schedule to be prescribed by the doctor.
